Synaptogenix Inc (SNPX)

[InTheTrenches]

This woman, treated under compassionate use, had ApoE4 gene mutation (not the PSEN1 variant):

http://www.wvgazettemail.com/article/20150718/gz01/150719268


---------------------------------------------

When they PR'd their Phase 2b trial initiation, they stated: "tolerability and efficacy of Bryostatin 1 in the treatment of moderately severe to severe Alzheimer’s Disease". No exclusion mentioned based on a genetic mutation.

Finally, the front page of their website says, "Entry criteria based on the MMSE score". MMSE is a Mini-Mental State Examination.